Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery of novel bergenin derivatives as immunosuppressive agents

Jan. 7, 2022

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Jan. 7, 2022

Life Biosciences to accelerate R&D activities on aging-related programs

Jan. 7, 2022

Chinese researchers describe new GLP-1 receptor agonists

Jan. 7, 2022

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Jan. 7, 2022

Janssen Pharmaceutica discloses Mcl-1 inhibitors

Jan. 7, 2022

French researchers patent new antibacterial compounds

Jan. 7, 2022

MRSA superbug has prickly origins

Jan. 7, 2022

Compact cell classifiers packaged into AAV vectors for precision tumor cell targeting

Jan. 7, 2022

Hemagglutinin anchor epitope unveiled as a target of broadly neutralizing antibodies

Jan. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...